date:Aug 10, 2012
Invisible Sentinel noted that the initial monoclonal products released are an important tool for the detection of foodborne pathogens, and can be utilized in research applications that require specificity and sensitivity.
The company plans to roll out additional specialty reagents to further accelerate research into microbial contamination and rapid detection strategies.
Invisible Sentinel CEO and co-founder Benjamin Pascal said the commercialization of the company's proprietary antibodies marks